Lovenox and Hyperthyroidism - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism is reported as a side effect among people who take Lovenox (enoxaparin sodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cordarone, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Hyperthyroidism when taking Lovenox. It is created by eHealthMe based on reports of 47,547 people who have side effects when taking Lovenox from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Hyperthyroidism?

Hyperthyroidism (over activity of the thyroid gland) is found to be associated with 977 drugs and 1,437 conditions by eHealthMe. Check the latest studies of Hyperthyroidism.

On Jul, 23, 2026

47,547 people reported to have side effects when taking Lovenox.
Among them, 54 people (0.11%) have Hyperthyroidism.

Among these 54 people:

How long have people been on Lovenox when they have Hyperthyroidism? *

What is the gender of people who have Hyperthyroidism when taking Lovenox? *

female: 51.92 %
male: 48.08 %

What is the age of people who have Hyperthyroidism when taking Lovenox? *

What are other drugs people take besides Lovenox? *

What are other side effects people have besides Hyperthyroidism? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 14 people, 25.93%
Stress And Anxiety: 11 people, 20.37%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 20.37%
Fatigue (feeling of tiredness): 11 people, 20.37%
Nausea And Vomiting: 11 people, 20.37%
High Blood Pressure: 11 people, 20.37%
Dehydration (dryness resulting from the removal of water): 10 people, 18.52%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 16.67%
Nausea (feeling of having an urge to vomit): 9 people, 16.67%
Malignant Neoplasm Progression (cancer tumour came back): 8 people, 14.81%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 12 people, 22.22%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 18.52%
Cardiac Failure: 9 people, 16.67%
Pain: 9 people, 16.67%
Hypercoagulation (increased tendency for clotting of the blood): 9 people, 16.67%
High Blood Pressure: 8 people, 14.81%
Stress And Anxiety: 6 people, 11.11%
Osteoporosis (bones weak and more likely to break): 6 people, 11.11%
Malignant Melanoma (skin cancer rises from melancytes): 5 people, 9.26%
Diabetes: 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and have Hyperthyroidism?

- Check whether Hyperthyroidism is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovenox:

Lovenox (48,149 reports)

Hyperthyroidism treatments and more:

Hyperthyroidism (26,832 reports)

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism:

Hyperthyroidism (977 drugs)

Browse all the conditions that are associated with Hyperthyroidism:

Hyperthyroidism (1,437 conditions)

Related publications that referenced our studies

Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .
Dulani S, Dulani R, Lele S, Diagavane S, Anjankar S, Jaiswal N, Subramaniam PS, Juneja R, "Chronic Subdural Haematoma in a Case of Hyperthyroidism Presenting with Papilledema", Chinese Medicine, 2012 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Lovenox) and Lovenox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.